#563: Oncology Pathways Under Pressure: From CAR-T Access Today to Longevity-Driven Care Tomorrow

Tuesday, June 16, 2026 4:15 PM to 5:15 PM · 1 hr. (America/New_York)
107AB
05: PersonalizedMed-ComboProd-Diagnostics

Information

By placing CAR-T within a broader trajectory—from breakthrough therapies today to longevity-driven oncology tomorrow—this session challenges stakeholders to rethink how access, value, and sustainability must evolve to keep pace with scientific progress.
CE
ACPECMERN
Session Level
Intermediate
Featured Topics
Therapeutic Pathways
Learning Objectives
Assess how CAR-T experience has revealed gaps in health technology assessment and reimbursement in the US and Europe; Examine how durable benefit, earlier intervention, and longer oncology horizons challenge current value, outcomes, and sustainability models; Apply multi-stakeholder and patient insights to inform evolving reimbursement and access approaches for potentially curative therapies.

Log in

See all the content and easy-to-use features by logging in or registering!